Science Explorer Back to mapMap
Institution · Fachklinik 360°

Most cited papers from Fachklinik 360°

What are the most cited papers from Fachklinik 360°?

The most cited paper from Fachklinik 360° is "Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist" (Barry Bresnihan, Jos� Maria Alvaro-Gracia, Mark Cobby et al., 1998), with 978 citations. Next come "Infections in patients with rheumatoid arthritis treated with biologic agents" (690) and "Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)" (647).

Showing 50 of 59 papers. Every paper with more than 42 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Barry Bresnihan, Jos� Maria Alvaro-Gracia, Mark Cobby et al. · Arthritis & Rheumatism Dec 1998 978
2 Infections in patients with rheumatoid arthritis treated with biologic agents Joachim Listing, Anja Strangfeld, S. Kary et al. · Arthritis & Rheumatism 27 Oct 2005 690
3 Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) Christian Antoni, Arthur Kavanaugh, Bruce W Kirkham et al. · Arthritis & Rheumatism Apr 2005 647
4 Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data José António Pereira da Silva, J W G Jacobs, J R Kirwan et al. · Annals of the Rheumatic Diseases Open access 18 Aug 2005 523
5 Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double‐blind, placebo‐controlled trial Siegfried Wassenberg, Rolf Rau, Paul Steinfeld et al. · Arthritis & Rheumatism 27 Oct 2005 309
6 Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: Comparison of patients according to their eligibility for major randomized clinical trials A. Zink, Anja Strangfeld, Matthias Schneider et al. · Arthritis & Rheumatism 30 Oct 2006 240
7 Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis D. Krause, B Schleusser, G. Herborn et al. · Arthritis & Rheumatism 2000 235
8 Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis D. van der Heijde, T. Dankert, F. H. M. Nieman et al. · Lara D. Veeken Open access Oct 1999 229
9 QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries Tuulikki Sokka, Hannu Kautiainen, Sergio Toloza et al. · Annals of the Rheumatic Diseases Open access 6 Apr 2007 220
10 Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID) Hans‐Peter Tony et al. · Arthritis Research & Therapy Open access 13 May 2011 212
11 The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year Arthur Kavanaugh, C E Antoni, D Gladman et al. · Annals of the Rheumatic Diseases Open access 27 Jan 2006 205
12 Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Joachim Listing, Anja Strangfeld, Jörn Kekow et al. · Arthritis & Rheumatism 29 Feb 2008 195
13 Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study J. Detert, Hans Bastian, Joachim Listing et al. · Annals of the Rheumatic Diseases 27 Jun 2012 189
14 Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low – results from RABBIT, the German biologics register Joachim Listing, Anja Strangfeld, Rolf Rau et al. · Arthritis Research & Therapy Open access 5 Apr 2006 181
15 Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study Leo B A van de Putte, R Rau, F C Breedveld et al. · Annals of the Rheumatic Diseases Open access 23 Nov 2003 179
16 Psoriatic arthritis imaging: a review of scoring methods D. van der Heijde, J Sharp, S Wassenberg et al. · Annals of the Rheumatic Diseases Open access 11 Feb 2005 173
17 The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis Rieke Alten, Hermann Gram, Leo A. B. Joosten et al. · Arthritis Research & Therapy Open access 5 Jun 2008 173
18 Adalimumab (a fully human anti-tumour necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials R. Rau · Annals of the Rheumatic Diseases Open access Nov 2002 157
19 Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index Gisela Westhoff, Rolf Rau, A. Zink · Arthritis & Rheumatism 29 Oct 2007 155
20 Treatment continuation in patients receiving biological agents or conventional DMARD therapy A. Zink, Joachim Listing, S. Kary et al. · Annals of the Rheumatic Diseases Open access 12 Feb 2005 153
21 S2e-Leitlinie: Therapie der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten Christoph Fiehn et al. · Zeitschrift für Rheumatologie Open access 29 Jun 2018 146
22 How to report radiographic data in randomized clinical trials in rheumatoid arthritis: Guidelines from a roundtable discussion Désirée M F M van der Heijde, Lee S. Simon, Josef S Smolen et al. · Arthritis Care & Research Apr 2002 144
23 A new method of scoring radiographic change in rheumatoid arthritis. Reina Rau, S Wassenberg, G. Herborn et al. · PubMed Nov 1998 144
24 Alternative and complementary therapies in osteoarthritis and cartilage repair Nicholas R. Fuggle et al. · Aging Clinical and Experimental Research Open access 13 Mar 2020 139
25 A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. Reina Rau, G. Herborn · PubMed Oct 1995 125
26 Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells Christof Iking‐Konert, B Ostendorf, O Sander et al. · Annals of the Rheumatic Diseases Open access 19 Mar 2005 124
27 Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group G. Westhoff, Reina Rau, A. Zink · Lara D. Veeken 11 Mar 2008 119
28 Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the National Database of the German Collaborative Arthritis Centres Stefanie Ziegler, Dörte Huscher, Kirsten Karberg et al. · Annals of the Rheumatic Diseases 7 May 2010 113
29 A method to score radiographic change in psoriatic arthritis Siegfried Wassenberg, V. Fischer-Kahle, G. Herborn et al. · Zeitschrift für Rheumatologie Jun 2001 102
30 Ist H15 (Harzextrakt von Boswellia serrata, „Weihrauch") eine sinnvolle Ergänzung zur etablierten medikamentösen Therapie der chronischen Polyarthritis? - Ergebnisse einer doppelblinden Pilotstudie Oliver Sander, G. Herborn, R. Rau · Zeitschrift für Rheumatologie 13 Mar 1998 94
31 Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID) M. Witt et al. · Lupus 20 Sep 2013 91
32 Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. Reina Rau, T Karger, G. Herborn et al. · PubMed Apr 1989 88
33 Identification of radiologic healing phenomena in patients with rheumatoid arthritis. Rolf Rau, Siegfried Wassenberg, G. Herborn et al. · PubMed Dec 2001 71
34 Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients R. Rau · British journal of rheumatology Mar 1997 71
35 S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012 K. Krüger et al. · Zeitschrift für Rheumatologie 28 Aug 2012 71
36 Association of the IL4R single‐nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis Iryna Prots, Alla Skapenko, Jörg Wendler et al. · Arthritis & Rheumatism 27 Apr 2006 69
37 Retardation of Radiologic Progression in Rheumatoid Arthritis With Methotrexate Therapy. A Controlled Study Reina Rau, G. Herborn, T Karger et al. · Arthritis & Rheumatism 10 Oct 1991 68
38 Study on the surface modification system with electrical discharge machine in the practical usage Toshio Moro, Naotake MOHRI, Hisashi Otsubo et al. · Journal of Materials Processing Technology 29 May 2004 68
39 Addition of a combination of onion (Allium cepa) and coconut (Cocos nucifera) to food of sheep stops gastrointestinal helminthic infections Heinz Mehlhorn, Saleh Al‐Quraishy, Khaled A. S. Al‐Rasheid et al. · Parasitology Research 30 Nov 2010 65
40 Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one‐year double‐blind study in 174 patients Reina Rau, G. Herborn, Heiner Menninger et al. · Lara D. Veeken Feb 2002 65
41 Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease‐modifying antirheumatic drug therapy Rolf Rau, G. Herborn · Arthritis & Rheumatism 1996 64
42 Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients Joerg Wendler, Gerd Rüdiger Burmester, Helmut Sörensen et al. · Arthritis Research & Therapy Open access 26 Mar 2014 61
43 Benefit and risk of methotrexate treatment in rheumatoid arthritis. Reina Rau, G. Herborn · PubMed 10 Feb 2005 60
44 Methotrexate treatment in Felty's syndrome Siegfried Wassenberg, G. Herborn, R. Rau · Lara D. Veeken Open access Aug 1998 59
45 Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry Norbert Walter Marschner, Michael D. Staehler, Lothar Müller et al. · Clinical Genitourinary Cancer Open access 9 Sep 2016 57
46 Long-term treatment of destructive rheumatoid arthritis with methotrexate. Rau R, B Schleusser, G. Herborn et al. · PubMed Oct 1997 57
47 Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis – for the LDPT-Study Group, R. Rau, Siegfried Wassenberg et al. · Zeitschrift für Rheumatologie Oct 2000 57
48 Is there an association between low serum 25-OH-D levels and the length of hospital stay in orthopaedic patients after arthroplasty? Gerrit Steffen Maier, Uwe Martin Maus, Djordje Lazovic et al. · Journal of Orthopaedics and Traumatology Open access 13 Jun 2016 56
49 Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate Reina Rau · British journal of rheumatology Nov 1998 56
50 The prevalence of vitamin D deficiency in patients with vertebral fragility fractures Gerrit Steffen Maier, Jörn Bengt Seeger, Konstantin Horas et al. · The Bone & Joint Journal 2015 56

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.